Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

Circulation

Volumn 108, Issue 5, 2003, Pages 512-515

  Danenberg, Haim D ^a,b,f   Szalai, Alexander J ^d   Swaminathan, Rajesh V ^a   Peng, Lin ^e   Chen, Zhiping ^c   Seifert, Philip ^a   Fay, William P ^e   Simon, Daniel I ^a,c   Edelman, Elazer R ^a,c  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f Bldg 56 322 ^*  (United States)

Author keywords

Heart disease; Inflammation; Risk factors; Thrombosis

Indexed keywords

C REACTIVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMORAL ARTERY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PREVENTION; PRIORITY JOURNAL; THROMBOSIS; TRANSGENIC MOUSE; TREATMENT PLANNING; WILD TYPE;

ANIMALS; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CAROTID ARTERY, COMMON; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMORAL ARTERY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LASERS; LEUKOCYTE COUNT; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; PHOTOCHEMISTRY; PLATELET COUNT; ROSE BENGAL; THROMBOSIS;

EID: 0043075885     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000085568.13915.1E     Document Type: Article

References (19)

1. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
2. Ridker PM. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Circulation. 2002;105:2583-2585.
3. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
4. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165-2168.
5. Pasceri V, Cheng JS, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 2001;103:2531-2534.
6. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913-919.
7. Szalai AJ, McCrory MA. Varied biologic functions of C-reactive protein: lessons learned from transgenic mice. Immunol Res. 2002;26:279-287.
8. Szalai AJ, Briles DE, Volanakis JE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol. 1995;155:2557-2563.
9. Reis E, Smyth S, Coller B. Mouse model of transluminal femoral artery injury. In: Simon DI, Rogers C, eds. Contemporary Cardiology: Vascular Disease and Injury: Preclinical Research. Totowa, NJ: Humana Press; 2001:103-113.
10. Nagashima M, Yin Z-F, Zhao L, et al. Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. J Clin Invest. 2002;109:101-110.
11. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
12. Roque M, Fallon JT, Badimon JJ, et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20:335-342.
13. Reis ED, Roque M, Dansky H, et al. Sulindac inhibits neointimal formation after arterial injury in wildtype and apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 2000;97:12764-12769.
14. Folsom A, Pankow J, Tracy R, et al. Association of C-reactive protein with markets of prevalent atherosclerotic disease. Am J Cardiol. 2001;88:112-117.
15. Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation. 2001;103:1718-1720.
16. Ballou S, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine. 1992;4:361-368.
17. Cermak J, Key N, Bach R, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513-520.
18. Napoleone E, Di Santo A, Bastone A, et al. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol. 2002;22:782-787.
19. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003;107:397-403.